HPV18 E7 Inhibits LATS1 Kinase and Activates YAP1 by Degrading PTPN14

Overview

Journal bioRxiv

Date 2024 Mar 18

PMID 38496413

Authors

William J Blakely

Joshua Hatterschide

Elizabeth A White

Affiliations

Soon will be listed here.

Abstract

High-risk human papillomavirus (HPV) oncoproteins inactivate cellular tumor suppressors to reprogram host cell signaling pathways. HPV E7 proteins bind and degrade the tumor suppressor PTPN14, thereby promoting the nuclear localization of the YAP1 oncoprotein and inhibiting keratinocyte differentiation. YAP1 is a transcriptional coactivator that drives epithelial cell stemness and self-renewal. YAP1 activity is inhibited by the highly conserved Hippo pathway, which is frequently inactivated in human cancers. MST1/2 and LATS1/2 kinases form the core of the Hippo kinase cascade. Active LATS1 kinase is phosphorylated on threonine 1079 and inhibits YAP1 by phosphorylating it on amino acids including serine 127. Here, we tested the effect of high-risk (carcinogenic) HPV18 E7 on Hippo pathway activity. We found that either PTPN14 knockout or PTPN14 degradation by HPV18 E7 decreased phosphorylation of LATS1 T1079 and YAP1 S127 in human keratinocytes and inhibited keratinocyte differentiation. Conversely, PTPN14-dependent differentiation required LATS kinases and certain PPxY motifs in PTPN14. Neither MST1/2 kinases nor the putative PTPN14 phosphatase active site were required for PTPN14 to promote differentiation. Taken together, these data support that PTPN14 inactivation or degradation of PTPN14 by HPV18 E7 reduce LATS1 activity, promoting active YAP1 and inhibiting keratinocyte differentiation.

References

Dyson N . The regulation of E2F by pRB-family proteins. Genes Dev. 1998; 12(15):2245-62. DOI: 10.1101/gad.12.15.2245. View

Hatterschide J, Bohidar A, Grace M, Nulton T, Kim H, Windle B . PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis. Proc Natl Acad Sci U S A. 2019; 116(14):7033-7042. PMC: 6452706. DOI: 10.1073/pnas.1819534116. View

Wilson K, Li Y, Yang N, Shen H, Orillion A, Zhang J . PTPN14 forms a complex with Kibra and LATS1 proteins and negatively regulates the YAP oncogenic function. J Biol Chem. 2014; 289(34):23693-700. PMC: 4156080. DOI: 10.1074/jbc.M113.534701. View

Wennmann D, Schmitz J, Wehr M, Krahn M, Koschmal N, Gromnitza S . Evolutionary and molecular facts link the WWC protein family to Hippo signaling. Mol Biol Evol. 2014; 31(7):1710-23. DOI: 10.1093/molbev/msu115. View

Hong A, Meng Z, Plouffe S, Lin Z, Zhang M, Guan K . Critical roles of phosphoinositides and NF2 in Hippo pathway regulation. Genes Dev. 2020; 34(7-8):511-525. PMC: 7111263. DOI: 10.1101/gad.333435.119. View

Callus B, Verhagen A, Vaux D . Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 2006; 273(18):4264-76. DOI: 10.1111/j.1742-4658.2006.05427.x. View

Mehra R, Vats P, Cieslik M, Cao X, Su F, Shukla S . Biallelic Alteration and Dysregulation of the Hippo Pathway in Mucinous Tubular and Spindle Cell Carcinoma of the Kidney. Cancer Discov. 2016; 6(11):1258-1266. PMC: 5096979. DOI: 10.1158/2159-8290.CD-16-0267. View

Qi S, Zhu Y, Liu X, Li P, Wang Y, Zeng Y . WWC proteins mediate LATS1/2 activation by Hippo kinases and imply a tumor suppression strategy. Mol Cell. 2022; 82(10):1850-1864.e7. DOI: 10.1016/j.molcel.2022.03.027. View

Chen R, Xie R, Meng Z, Ma S, Guan K . STRIPAK integrates upstream signals to initiate the Hippo kinase cascade. Nat Cell Biol. 2019; 21(12):1565-1577. DOI: 10.1038/s41556-019-0426-y. View

10.

White E, Kramer R, Hwang J, Pores Fernando A, Naetar N, Hahn W . Papillomavirus E7 oncoproteins share functions with polyomavirus small T antigens. J Virol. 2014; 89(5):2857-65. PMC: 4325735. DOI: 10.1128/JVI.03282-14. View

11.

Yimlamai D, Christodoulou C, Galli G, Yanger K, Pepe-Mooney B, Gurung B . Hippo pathway activity influences liver cell fate. Cell. 2014; 157(6):1324-1338. PMC: 4136468. DOI: 10.1016/j.cell.2014.03.060. View

12.

Chan E, Nousiainen M, Chalamalasetty R, Schafer A, Nigg E, Sillje H . The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene. 2005; 24(12):2076-86. DOI: 10.1038/sj.onc.1208445. View

13.

Hahn W, Dessain S, Brooks M, King J, Elenbaas B, Sabatini D . Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol. 2002; 22(7):2111-23. PMC: 133688. DOI: 10.1128/MCB.22.7.2111-2123.2002. View

14.

Knight J, Sung V, Kuzmin E, Couzens A, de Verteuil D, Ratcliffe C . KIBRA (WWC1) Is a Metastasis Suppressor Gene Affected by Chromosome 5q Loss in Triple-Negative Breast Cancer. Cell Rep. 2018; 22(12):3191-3205. PMC: 5873529. DOI: 10.1016/j.celrep.2018.02.095. View

15.

Uliana F, Ciuffa R, Mishra R, Fossati A, Frommelt F, Keller S . Phosphorylation-linked complex profiling identifies assemblies required for Hippo signal integration. Mol Syst Biol. 2023; 19(4):e11024. PMC: 10090947. DOI: 10.15252/msb.202211024. View

16.

Primi M, Rangarajan E, Patil D, Izard T . Conformational flexibility determines the Nf2/merlin tumor suppressor functions. Matrix Biol Plus. 2021; 12:100074. PMC: 8318988. DOI: 10.1016/j.mbplus.2021.100074. View

17.

McBride A . Human papillomaviruses: diversity, infection and host interactions. Nat Rev Microbiol. 2021; 20(2):95-108. DOI: 10.1038/s41579-021-00617-5. View

18.

Poernbacher I, Baumgartner R, Marada S, Edwards K, Stocker H . Drosophila Pez acts in Hippo signaling to restrict intestinal stem cell proliferation. Curr Biol. 2012; 22(5):389-96. DOI: 10.1016/j.cub.2012.01.019. View

19.

Dickson M, Hahn W, Ino Y, Ronfard V, Wu J, Weinberg R . Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol. 2000; 20(4):1436-47. PMC: 85304. DOI: 10.1128/MCB.20.4.1436-1447.2000. View

20.

Singh G, Mishra S, Chander H . KIBRA Team Up with Partners to Promote Breast Cancer Metastasis. Pathol Oncol Res. 2019; 26(2):627-634. DOI: 10.1007/s12253-019-00660-x. View